Why some RNA drugs work better than others
CSHL Associate Professor Justin Kinney, Krainer, and postdoc Yuma Ishigami have figured out why some splicing-based drugs tend to work better than others.
- CSHL Associate Professor Justin Kinney, Krainer, and postdoc Yuma Ishigami have figured out why some splicing-based drugs tend to work better than others.
- To better understand how this drug works, the Kinney and Krainer labs analyzed risdiplam's interactions with RNA.
- "Our new study provides insights into the action and specificity of splice-modifying drugs," Krainer says.
- "This should facilitate the development of more effective drugs and drug combinations for a variety of diseases."